18 November 2024 · 1 min read
Some really interesting news from Sanofi recently, in the hot AI in clinical trials space: Format...
Formation Bio, in collaboration with Sanofi and OpenAI, has introduced Muse, an AI-powered tool designed to optimize patient recruitment in clinical trials. I think it will be fascinating to watch how this three-party collaboration — Big Pharma, Health Tech, and Large Tech — evolves, and I wouldn't be surprised to see more of these partnerships emerge in the coming year.
Filed under AI in Pharma · Tech Bio
Some really interesting news from Sanofi recently, in the hot AI in clinical trials space: Formation Bio, in collaboration with Sanofi and OpenAI, has introduced Muse, an AI-powered tool designed to optimize patient recruitment in clinical trials. Some interesting elements in there, like a dedicated LLM agent that incorporates Institutional Review Board and regulatory guidelines, and auto-generation of recruitment materials and pre-screening questionnaires.
In the bigger picture, it will be fascinating to watch how this three-party collaboration - Big Pharma, Health Tech, and Large Tech - evolves over time. Given the momentum in the sector, I wouldn't be surprised to see more of these partnerships emerge in the coming year as AI continues to reshape clinical operations and healthcare at large.
Related insights
18 Jun 2025
An interesting discussion on AI in drug discovery and development with Thirupathi Pattipaka from...
19 May 2026
The rise of agentic in drug R&D - Owkin & AZ
12 May 2026
Isomorphic about to raise $2bn - and why I'm not sure that's a good thing
31 Mar 2026
Eli Lilly and Insilico Medicine: what three AI drug discovery deals signal